G Bondolfi

Summary

Affiliation: University Hospital
Country: Switzerland

Publications

  1. ncbi The effect of fluoxetine on the pharmacokinetics and safety of risperidone in psychotic patients
    G Bondolfi
    Dépatrement universitaire de psychiatrie adulte, Site de Cery, Pirlly Lausanne, Switzerland
    Pharmacopsychiatry 35:50-6. 2002
  2. ncbi A stepwise drug treatment algorithm to obtain complete remission in depression: a Geneva study
    G Bondolfi
    Hopitaux Universitaires de Geneve, Departement de Psychiatrie, Service de Psychiatrie Adulte
    Swiss Med Wkly 136:78-85. 2006
  3. ncbi Prevalence of pathological gambling in Switzerland after the opening of casinos and the introduction of new preventive legislation
    G Bondolfi
    Department of Psychiatry, Geneva University Hospitals, Service de Psychiatrie Adulte, Geneva
    Acta Psychiatr Scand 117:236-9. 2008
  4. ncbi Self- and clinician-rated Montgomery-Asberg Depression Rating Scale: evaluation in clinical practice
    G Bondolfi
    Geneva University Hospitals, Department of Psychiatry, Division of Adult Psychiatry, Geneva, Switzerland
    J Affect Disord 121:268-72. 2010
  5. ncbi Depression relapse prophylaxis with Mindfulness-Based Cognitive Therapy: replication and extension in the Swiss health care system
    Guido Bondolfi
    Department of Psychiatry, Geneva University Hospital, Switzerland
    J Affect Disord 122:224-31. 2010
  6. ncbi Mindfulness-based cognitive therapy for bipolar disorder: a feasibility trial
    B Weber
    Geneva University Hospital, Department of Psychiatry, Bipolar Program, 6 8, rue du 31 Décembre, 1207 Geneva, Switzerland
    Eur Psychiatry 25:334-7. 2010
  7. ncbi Self-rated residual symptoms do not predict 1-year recurrence of depression
    G Bertschy
    Division of Adult Psychiatry, Department of Psychiatry, University Hospitals of Geneva, 2, chemin du Petit Bel Air, 1225 Chene Bourg, Geneva, Switzerland
    Eur Psychiatry 25:52-7. 2010
  8. ncbi [Psychiatry]
    M Kosel
    Service de Psychiatrie Adulte, HUG Rue du 31 Décembre 6 8, 1207 Genève
    Rev Med Suisse 6:137-40. 2010
  9. ncbi Lithium dose prediction based on 24 hours single dose levels: a prospective evaluation
    N Gervasoni
    Departement de Psychiatrie, Clinique de Psychiatrie Adulte Programme Dépression, Hopitaux Universitaires de Geneve, Domaine de Belle Idée, 16 18, bd Saint Georges, CH 1205 Geneva, Switzerland
    Pharmacol Res 48:649-53. 2003

Detail Information

Publications9

  1. ncbi The effect of fluoxetine on the pharmacokinetics and safety of risperidone in psychotic patients
    G Bondolfi
    Dépatrement universitaire de psychiatrie adulte, Site de Cery, Pirlly Lausanne, Switzerland
    Pharmacopsychiatry 35:50-6. 2002
    ..The severity and incidence of extrapyramidal symptoms and adverse events did not significantly increase when fluoxetine was added...
  2. ncbi A stepwise drug treatment algorithm to obtain complete remission in depression: a Geneva study
    G Bondolfi
    Hopitaux Universitaires de Geneve, Departement de Psychiatrie, Service de Psychiatrie Adulte
    Swiss Med Wkly 136:78-85. 2006
    ..We compare several treatment options for SSRI (selective serotonin reuptake inhibitor) non-responders and test the feasibility of the algorithm in clinical conditions...
  3. ncbi Prevalence of pathological gambling in Switzerland after the opening of casinos and the introduction of new preventive legislation
    G Bondolfi
    Department of Psychiatry, Geneva University Hospitals, Service de Psychiatrie Adulte, Geneva
    Acta Psychiatr Scand 117:236-9. 2008
    ..This replication study made it possible to compare the prevalence rates of PG measured before and after the introduction of casinos and new preventive legislation...
  4. ncbi Self- and clinician-rated Montgomery-Asberg Depression Rating Scale: evaluation in clinical practice
    G Bondolfi
    Geneva University Hospitals, Department of Psychiatry, Division of Adult Psychiatry, Geneva, Switzerland
    J Affect Disord 121:268-72. 2010
    ....
  5. ncbi Depression relapse prophylaxis with Mindfulness-Based Cognitive Therapy: replication and extension in the Swiss health care system
    Guido Bondolfi
    Department of Psychiatry, Geneva University Hospital, Switzerland
    J Affect Disord 122:224-31. 2010
    ..The present study is the first independent replication trial comparing MBCT+TAU to TAU alone across both language and culture (Swiss health care system)...
  6. ncbi Mindfulness-based cognitive therapy for bipolar disorder: a feasibility trial
    B Weber
    Geneva University Hospital, Department of Psychiatry, Bipolar Program, 6 8, rue du 31 Décembre, 1207 Geneva, Switzerland
    Eur Psychiatry 25:334-7. 2010
    ..MBCT has been mostly evaluated with remitted unipolar depressed patients and little is known about this treatment in bipolar disorder...
  7. ncbi Self-rated residual symptoms do not predict 1-year recurrence of depression
    G Bertschy
    Division of Adult Psychiatry, Department of Psychiatry, University Hospitals of Geneva, 2, chemin du Petit Bel Air, 1225 Chene Bourg, Geneva, Switzerland
    Eur Psychiatry 25:52-7. 2010
    ..In the absence of a specific instrument for the assessment of residual symptoms, a new 25-item Depression Residual Symptom Scale (DRSS) was elaborated and tested for recurrence prediction over a 1-year follow-up...
  8. ncbi [Psychiatry]
    M Kosel
    Service de Psychiatrie Adulte, HUG Rue du 31 Décembre 6 8, 1207 Genève
    Rev Med Suisse 6:137-40. 2010
    ..The persistence of residual depressive symptoms is associated with increased risk of relapse: their recognition and treatment are illustrated in this article...
  9. ncbi Lithium dose prediction based on 24 hours single dose levels: a prospective evaluation
    N Gervasoni
    Departement de Psychiatrie, Clinique de Psychiatrie Adulte Programme Dépression, Hopitaux Universitaires de Geneve, Domaine de Belle Idée, 16 18, bd Saint Georges, CH 1205 Geneva, Switzerland
    Pharmacol Res 48:649-53. 2003
    ..Although there was no control group, the prediction test often allowed us to use a higher dose than the usual fixed dose whose amount is limited by the risk of overdosing for the slower metabolizers...